Who is sponsoring NCT05690074?

NCT05690074 is sponsored by University Hospital, Motol.

What drugs are being tested in NCT05690074?

Interventions in NCT05690074: Spectra Wave Writer™ Spinal Cord Stimulator System.

What condition does NCT05690074 study?

NCT05690074 studies Spinal Cord Injuries.

Is NCT05690074 still recruiting?

NCT05690074 is currently status unknown. Last updated 16 March 2023.

Last reviewed 2023-03-16 · How we verify

NCT05690074

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Epidural Stimulation in Chronic Spinal Cord Injury Patients

Status unknown NA Last updated 16 March 2023

What this trial tests

NA trial testing Spectra Wave Writer™ Spinal Cord Stimulator System in Spinal Cord Injuries in 5 participants. Status unknown.

Timeline

1 January 2023

Primary endpoint
1 December 2025

30 December 2025

Quick facts

Lead sponsor	University Hospital, Motol
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	5
Start date	1 January 2023
Primary completion	1 December 2025
Estimated completion	30 December 2025
Sites	1 location across Czechia

Drugs / interventions tested

Spectra Wave Writer™ Spinal Cord Stimulator System

Conditions studied

Spinal Cord Injuries — all drugs for Spinal Cord Injuries →

Sponsor

University Hospital, Motol

Who can join

Adults 18 to 60, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators propose to demonstrate that epidural stimulation (ES) can be used to recover significant levels of autonomic control of cardiovascular, urinary and sexual function as well as the ability to voluntarily control leg movements below the injury level. This intervention would provide an immediate therapeutic alternative to individuals who now have no recourse for treatment. In addition investigators suggest to prove on functional magnetic resonance imaging if there are some significant changes before and after the stimulation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of epidural spinal cord stimulation in individuals with sensorimotor complete spinal cord injury: a pilot study.
Rybka V, Sediva K, Spackova L, Kolar P, et al · · 2025 · PMID 40673222 · DOI 10.3389/fnsys.2025.1622033

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

NCT07109804 — Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury · NA · recruiting
NCT07472985 — Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial · NA · recruiting
NCT07210411 — Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury · NA · recruiting
NCT07488793 — Remote Ischemic Conditioning for PwSCI · NA · recruiting
NCT07536386 — Self-balancing Personal Exoskeleton for SCI (WIP) · NA · recruiting

Other University Hospital, Motol trials

Trials by the same sponsor.

NCT07149142 — Pediatric Artificial Intelligence for Retinopathy Screening in Children With Type 1 Diabetes · NA · not yet recruiting
NCT07482969 — Prevalence of Symptomatic Gastroesophageal Reflux Disease in Czech Children (Czech GERDKids) · recruiting
NCT06868823 — Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation · recruiting
NCT06102421 — Evaluation of the Effectiveness of Extracorporeal Shockwave Therapy in Patients With Patellar Tendinopathy on Its Microm · completed
NCT07103317 — Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05690074 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Motol
Last refreshed: 16 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05690074.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing